Neura Parse supports workflow, integration, local-processing, research, and evidence-system engineering. We do not represent a general-purpose platform as a clinically validated, HIPAA-compliant, FDA-cleared, or CE-marked medical device without product- and deployment-specific evidence.
Concept visualizationLocal
Processing option
Human
Clinical authority
Protocol
Research anchor
Specific
Regulatory scope
A useful system must fit clinical roles, patient context, interoperability, privacy, safety, model limitations, escalation, procurement, validation, and post-deployment monitoring.
01
A technically accurate output can still create delay, alarm fatigue, duplicate work, automation bias, or unclear responsibility if it arrives in the wrong workflow.
Acceptance questionDoes the right person receive the right evidence at a point where they can safely act?
02
DICOM, HL7 v2, FHIR, device streams, laboratory data, notes, identities, consent, and local mappings carry different semantics and governance.
Acceptance questionCan data lineage, patient identity, terminology, transformation, and access be audited end to end?
03
Model performance varies by population, site, device, protocol, prevalence, workflow, and intended use. Benchmarks do not substitute for the applicable validation pathway.
Acceptance questionIs the evaluation representative of the intended users, data, setting, and decision?
04
Models, datasets, devices, clinical practice, software dependencies, and regulations evolve. Each change may affect the validated state.
Acceptance questionCan the team detect drift, assess impact, approve change, and roll back safely?
Healthcare AI should begin with an intended use, a named user, and the decision the system is meant to support. The same output can be helpful in one workflow and unsafe or distracting in another. Presentation timing, uncertainty, source context, escalation, override, and responsibility therefore belong in the design alongside model performance. A clinician or researcher needs to see enough evidence to judge the output without being encouraged to surrender professional authority to it.
Interoperability and privacy shape what is technically possible. Images, observations, laboratory results, notes, device streams, identity, consent, and terminology may cross DICOM, HL7, FHIR, and local interfaces with different semantics. Local or edge processing can reduce latency or data movement in some settings, but it does not remove the need for access control, purpose limitation, lineage, cybersecurity, retention, and site-specific validation.
Quantum sensing and quantum-enabled biomedical research should be treated as research programs, not clinical claims. A meaningful study defines the physical signal, protocol, controls, calibration, classical comparator, uncertainty, and negative-result policy before choosing a quantum technique. That discipline creates useful evidence even when a proposed advantage is not observed, and it keeps exploratory work clearly separated from diagnostic, therapeutic, or regulated product assertions.
The operating loop preserves patient and protocol context, model version, uncertainty, clinician disposition, and downstream outcome without presenting AI as autonomous clinical authority.
Receive the minimum necessary data with identity, consent, device, protocol, quality, terminology, and access context.
Data lineage · consent/access · protocol · quality record
Run a model or rule set inside its intended-use boundary and attach version, limitations, uncertainty, and relevant source evidence.
Model version · input quality · output · uncertainty · limitations
Present information in the clinician or researcher workflow with escalation, override, rationale, and clear responsibility.
Reviewer identity · disposition · escalation · action receipt
Track technical behavior, data drift, workflow impact, safety events, feedback, and authorized changes separately.
Monitoring record · incident · change assessment · updated validation
Capabilities support engineering and research. Intended use, clinical performance, privacy obligations, cybersecurity, quality management, and regulatory approval are established for the specific product and deployment.
Route referrals, second reads, alerts, exceptions, documentation, research tasks, and approvals with role, timing, escalation, and audit context.
Map and test DICOM, HL7 v2, FHIR, identity, terminology, device, and local-system interfaces with explicit transformation and ownership.
Package approved models for local infrastructure or devices with target benchmarks, access controls, observability, release identity, and controlled export.
Define intended use, populations, sites, devices, reference standard, error costs, workflow outcomes, subgroup review, drift, and change controls.
Structure protocols, calibration, controls, classical baselines, resource estimates, privacy boundaries, uncertainty, and negative results.
The reference flow separates source systems, local processing, workflow orchestration, clinician review, and evidence so each boundary can be governed and validated.
EHR, PACS, LIS, devices, imaging, notes, research datasets, protocol, identity, consent, and terminology remain authoritative at source.
DICOM · HL7 v2 · FHIR · device interface · controlled research data
Mapping, identity, access, consent, minimum-necessary data, terminology, transformation, retention, and audit are explicit services.
Interface engine · IAM · consent · terminology · lineage · audit
Approved models or experiments run on defined infrastructure with version, input checks, observability, and export policy.
NeuralOS where appropriate · local server · model runtime · QFlow research record
NowFlow connects review, escalation, second read, documentation, protocol tasks, approvals, and downstream systems.
Role-specific queue · human review · exception · action receipt
Evaluation, limitations, incidents, drift, change, retraining, cybersecurity, and regulatory artifacts remain tied to the product version and intended use.
Protocol · model card · monitoring · change assessment · CAPA
Profiles are framed as workflow, integration, and evaluation work. They do not claim clinical accuracy, device approval, or regulatory compliance.
Route a validated model output beside source images and clinical context for specialist review, uncertainty handling, discrepancy tracking, and escalation.
Aggregate authorized alerts, patient and device context, suppress duplicate workflow noise, and route prioritized items to the accountable clinical role.
Run approved research models inside a controlled environment with dataset identity, access, reproducible configuration, result export, and audit.
Compare a sensing or simulation method with classical baselines under a pre-registered protocol, calibration plan, uncertainty, and privacy constraints.
Healthcare laws, standards, and approvals attach to a specific legal entity, intended use, product, market, site, and operating model. They are design inputs here—not blanket badges.
Map lawful basis, roles, minimum necessary data, access, security, retention, patient rights, incident response, and contractual responsibilities.
Define semantic and transport interoperability, terminology, identity, validation, error handling, and local profiles.
Intended use, classification, quality management, risk, clinical evaluation, cybersecurity, software lifecycle, and post-market monitoring require a sponsor-led pathway.
Assess role, risk classification, data governance, transparency, human oversight, accuracy, robustness, cybersecurity, and monitoring where applicable.
External context is linked separately from Neura Parse capability claims.
Source 01 · FDA
Primary U.S. context for AI-enabled medical devices and the importance of product-specific authorization and lifecycle oversight.
Source 02 · HL7
Primary standard reference for healthcare data resources, APIs, implementation guides, and conformance.
Source 03 · DICOM Standards Committee
Primary imaging-interoperability context for medical images, related information, services, and conformance.
Source 04 · European Commission
Primary EU policy context for AI risk, obligations, implementation, and governance.
Source 05 · NIST
Current primary metrology context for quantum sensor types, measurement principles, calibration considerations, limitations, and possible biomedical applications.
Source 06 · NIST
Primary research context for quantum-light methods in biological measurement and imaging; it supports protocol and analytical-evidence framing, not a clinical-readiness claim.
Service
Frame intended use, operating workflow, data, risk, evidence, and investment gates.
Service
Map and test DICOM, HL7, FHIR, identity, terminology, and local systems.
Service
Design evaluation, human oversight, monitoring, change, and incident evidence.
Service
Structure research protocol, baselines, calibration, uncertainty, and decision records.
We can scope workflow and integration engineering, local-processing evaluation, research evidence, and governance without implying clinical validation or regulatory status that has not been established.
